title: Immunomodulatory treatments in epilepsy.
abstract: The role of immunity and inflammation appears to be an integral part of the pathogenic processes associated with some seizures, particularly with refractory epilepsy. Prompt treatment with immunotherapy may lead to better outcomes. Immune treatment options for treatment of epilepsy include therapies such as corticosteroids, immunoglobulins, plasmapheresis, or steroid-sparing drugs such as azathioprine. Recent alternatives have included even more aggressive treatment with cyclophosphamide, anti-pre-B-lymphocyte monoclonal antibody rituximab, and monoclonal antibodies such as efalizumab or natalizumab, which are presently used for other inflammatory disorders. Randomized controlled trials of immunotherapy in presumed autoimmune epilepsy are needed to provide further support for the rapid use of immunotherapy in patients with immune mediated epilepsy.
authors.affiliation: Section of Neurology, St. Christopher's Hospital for Children, Department of Pediatrics, Drexel University College of Medicine, Philadelphia, PA.. Electronic address: joseph.melvin@drexelmed.edu.
authors.forename: Joseph J
authors.initials: JJ
authors.lastname: Melvin
authors.affiliation: Section of Neurology, St. Christopher's Hospital for Children, Department of Pediatrics, Drexel University College of Medicine, Philadelphia, PA.
authors.forename: H
authors.initials: H
authors.lastname: Huntley Hardison
mesh_terms: D000818:Animals; D004827:Epilepsy / Q000276:immunology* / Q000628:therapy*; D006801:Humans; D056747:Immunomodulation